Detalles de la búsqueda
1.
Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL.
Cancers (Basel)
; 15(19)2023 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835517
Resultados
1 -
1
de 1
1
Próxima >
>>